🇺🇸 FDA
Patent

US 6903106

Polymorph of N-methyl-N-(3-{3-[2-thienylcarbonyl]-pyrazol-[1,5-α]-pyrimidin-7-yl}phenyl)acetamide and compositions and methods related thereto

expired A61PA61P21/02A61P25/00

Quick answer

US patent 6903106 (Polymorph of N-methyl-N-(3-{3-[2-thienylcarbonyl]-pyrazol-[1,5-α]-pyrimidin-7-yl}phenyl)acetamide and compositions and methods related thereto) held by Neurocrine Biosciences, Inc. expires Mon Jun 02 2025 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
Neurocrine Biosciences, Inc.
Grant date
Tue Jun 07 2005 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 02 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
42
CPC classes
A61P, A61P21/02, A61P25/00, A61P25/20, A61P25/22